{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:09:53Z","timestamp":1793761793858,"version":"4.6.1"},"reference-count":109,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":2216,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2000,1]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>:<\/jats:bold>In 1963, Professor Vincent P. Dole at the Rockefeller University formed a small team to develop a pharmacotherapy for the management of heroin addiction. They hypothesized that heroin addiction is a disease of the brain with behavioral manifestations, and not merely a personality disorder or criminal behavior and began to address the specific question of whether a long\u2010acting opioid agonist could be used in the long\u2010term maintenance treatment of heroin addiction. Over the next 35 years, many studies documented the safety, efficacy and effectiveness of methadone pharmacotherapy for heroin addiction, but Federal regulations and stigmatization of heroin addiction prevented implementation of treatment. Finally, in 1999, NIH published a report unequivocally supporting methadone maintenance pharmacotherapy for heroin addiction. Two other effective opioid agonist treatments have been developed: the even longer acting opioid agonist l\u2010alpha\u2010acetylmethadol (LAAM) has been approved for pharmacotherapy for heroin addiction, and still under study is the opioid partial agonist\u2010antagonist buprenorphine\u2010naloxone combination. A variety of studies, both laboratory based and clinical, have revealed the mechanisms of action of long\u2010acting opioid agonists in treatment, including prevention of disruption of molecular, cellular and physiologic events and, in fact, allowing normalization of those functions disrupted by chronic heroin use. Recent molecular biological studies have revealed single nucleotide polymorphisms of the human \u03bc opioid receptor gene; the m opioid receptor is the site of action of heroin, the major opiate drug of abuse, analgesic agents such as morphine, and the major treatment agents for heroin addiction. These findings support the early hypotheses of our laboratory that addiction may be due to a combination of genetic, drug\u2010induced and environmental (including behavioral) factors and also, that atypical stress responsivity may contribute to the acquisition and persistence of, as well as relapse to, use of addictive drugs.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2000.tb06683.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T19:17:12Z","timestamp":1279653432000},"page":"186-216","source":"Crossref","is-referenced-by-count":217,"title":["Methadone\u2010Related Opioid Agonist Pharmacotherapy for Heroin Addiction: History, Recent Molecular and Neurochemical Research and Future in Mainstream Medicine"],"prefix":"10.1111","volume":"909","author":[{"given":"MARY JEANNE","family":"KREEK","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_4_2_2","unstructured":"Rettig R.A. & A. Yarmolinsky Eds. 1995. Federal Regulation of Methadone Treatment. National Academy of Sciences National Academy Press. Washington DC."},{"key":"e_1_2_4_3_2","doi-asserted-by":"crossref","unstructured":"Kreek M.J. 1991. Using methadone effectively: achieving goals by application of laboratory clinical and evaluation research and by development of innovative programs.InImproving Drug Abuse Treatment: National Institute of Drug Abuse Research Monograph Series. R. Pickenset al. Eds. 106: 245\u2013266. Supt. of Docs. U.S. Gov. Print. Off. Washington DC.","DOI":"10.1037\/e496292006-013"},{"key":"e_1_2_4_4_2","unstructured":"Kreek M.J. 1992. Rationale for maintenance pharmacotherapy of opiate dependence.InAddictive States. C.P. O'Brien & J.H. Jaffe Eds.: 205\u2013230. Raven Press Ltd. New York."},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1966.00290160004002"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02532387"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.39.070170.004133"},{"key":"e_1_2_4_8_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0022-3565(25)28669-4","article-title":"Localization of d and l\u2010methadone after intraventricular injection into rat brain","volume":"175","author":"Ingoglia N.A.","year":"1970","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.8.1742"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.179.4077.1011"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.70.7.1947"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1973.tb01477.x"},{"key":"e_1_2_4_13_2","unstructured":"Kreek M.J. 1992. Epilogue: medical maintenance treatment for heroin addiction from a retrospective and prospective viewpoint.InState Methadone Maintenance Treatment Guidelines. Office for Treatment Improvement Division for State Assistance pp. 255\u2013272."},{"key":"e_1_2_4_14_2","unstructured":"Kreek M.J. 2000. Opiates opioids SNP's and the addictions: Nathan B. Eddy Memorial Award for lifetime excellence in drug abuse research lecture.InProblems of Drug Dependence 1999. Proceedings of the 61st Annual Scientific Meeting of the College on problems of Drug Dependence. L.S. Harris Ed. National Institute of Drug Abuse Research Monograph Series. In press."},{"key":"e_1_2_4_15_2","doi-asserted-by":"crossref","unstructured":"Kreek M.J. 1996. Long\u2010term pharmacotherapy for opiate (primarily heroin) addiction: opiate Agonists.InPharmacological Aspects of Drug Dependence: Toward an Integrated Neurobehavioral Approach. C. R. Schuster & M. J. Kuhar Eds.: 487\u2013562. Springer\u2010Verlag. Berlin Germany.","DOI":"10.1007\/978-3-642-60963-3_14"},{"key":"e_1_2_4_16_2","unstructured":"Kling M.et al.1997. Opioid receptor binding in methadone maintained former heroin addicts by PET imaging using [18F]cyclofoxy.InProblems of Drug Dependence 1996. Proceedings of the 58th Annual Scientific Meeting of the College on Problems of Drug Dependence. L.S. Harris Ed. National Institute of Drug Abuse Research Monograph Series. 174: 120. Supt. of Docs. U.S. Gov. Print. Off. Washington DC. DHHS Pub. No. (ADM) 97\u20134236."},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(00)92558-5"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1972135part1633"},{"issue":"23","key":"e_1_2_4_19_2","first-page":"2773","article-title":"Plasma and urine levels of methadone","volume":"73","author":"Kreek M.J.","year":"1973","journal-title":"NYS J. Med."},{"key":"e_1_2_4_20_2","unstructured":"Hachey D.L. D.H. Mattson & M.J. Kreek. 1976. Quantitation of methadone in biological fluids using deuterium labeled internal standards.InProceedings of the Second International Conference on Stable Isotopes. E.R. Klein & P.D. Klein Eds. ERDA\u2010CONF\u2010751027: 518\u2013523. National Technical Information Source. U.S. Dept. of Commerce. Springfield VA."},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600661120"},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(79)90343-6"},{"key":"e_1_2_4_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600710110"},{"key":"e_1_2_4_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198405103101902"},{"key":"e_1_2_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(01)91836-9"},{"issue":"1","key":"e_1_2_4_26_2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cpt197518196","article-title":"Disposition of acetylmethadol in relation to pharmacologic action","volume":"18","author":"Kauji R.F.","year":"1975","journal-title":"Clin. Pharm. Ther."},{"key":"e_1_2_4_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197605132942008"},{"key":"e_1_2_4_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1976.tb27945.x"},{"key":"e_1_2_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(78)90033-9"},{"key":"e_1_2_4_30_2","unstructured":"Kreek M.J. 1978. Effects of drugs and alcohol on opiate disposition and action.InFactors Affecting the Action of Narcotics. M.W. Adler L. Manara & R. Samnin Eds.: 717\u2013739. Raven Press. New York."},{"key":"e_1_2_4_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1980.tb02543.x"},{"key":"e_1_2_4_32_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-94-3-349"},{"key":"e_1_2_4_33_2","doi-asserted-by":"crossref","unstructured":"Kreek M.J. 1983. Factors modifying the pharmacological effectiveness of methadone.InResearch in the Treatment of Narcotic Addiction: State of the Art. J.R. Cooperet al. Eds.: 95\u2013114. National Institute on Drug Abuse Monograph DHHS Pub. # (ADM) 83\u20131281.","DOI":"10.1037\/e471722004-001"},{"key":"e_1_2_4_34_2","first-page":"35","article-title":"Opioid interactions with alcohol","volume":"3","author":"Kreek M.J.","year":"1984","journal-title":"J. Addictive Dis."},{"key":"e_1_2_4_35_2","first-page":"265","article-title":"Drug interactions in humans related to drug abuse and its treatment","volume":"6","author":"Kreek M.J.","year":"1990","journal-title":"Mod. Meth. Pharmacol."},{"key":"e_1_2_4_36_2","unstructured":"Kreek M.J. 1987. Multiple drug abuse patterns and medical consequences.InPsychopharmacology: The Third Generation of Progress. H.Y. Meltzer Ed.: 1597\u20131604. Raven Press. New York."},{"key":"e_1_2_4_37_2","unstructured":"Kreek M.J. 1995. Pharmacology and medical aspects of methadone treatment.InFederal Regulation of Methadone Treatment. R.A. Rettig & A. Yarmolinsky Eds.: 37\u201360. National Academy of Sciences National Academy Press. Washington DC."},{"key":"e_1_2_4_38_2","doi-asserted-by":"crossref","unstructured":"Kreek M.J. 1996. Long\u2010term pharmacotherapy for opiate (primarily heroin) addiction: opiate antagonists and partial agonists.InPharmacological Aspects of Drug Dependence: Toward an Integrated Neurobehavioral Approach. C.R. Schuster & M.J. Kuhar Eds.: 563\u2013592. Springer\u2010Verlag. Berlin.","DOI":"10.1007\/978-3-642-60963-3_15"},{"key":"e_1_2_4_39_2","first-page":"232","article-title":"Opiates, opioids and addiction","volume":"1","author":"Kreek M.J.","year":"1996","journal-title":"Mol. Psych."},{"key":"e_1_2_4_40_2","doi-asserted-by":"publisher","DOI":"10.1006\/smns.1997.0114"},{"key":"e_1_2_4_41_2","doi-asserted-by":"crossref","unstructured":"Borg L. & M.J. Kreek. 1998. Pharmacology of opiates.InHandbook of Substance Abuse: Neurobehavioral Pharmacology. Tarteret al. Eds.: 331\u2013341. Plenum. New York.","DOI":"10.1007\/978-1-4757-2913-9_23"},{"key":"e_1_2_4_42_2","unstructured":"Kreek M.J. 1972. Medical safety side effects and toxicity of methadone. In Proceedings of the Fourth National Conference on Methadone Treatment NAPAN\u2010NIMH. 171\u2013174."},{"key":"e_1_2_4_43_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-77-4-598"},{"key":"e_1_2_4_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1973.03220060039009"},{"key":"e_1_2_4_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1978.tb16769.x"},{"key":"e_1_2_4_46_2","unstructured":"Kreek M.J. 1973. Physiological implications of methadone treatment.InMethadone Treatment Manual.: 85\u201391. U.S. Dept. of Justice (USGPO) #2700\u201000227. Washington DC."},{"key":"e_1_2_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(93)90110-C"},{"key":"e_1_2_4_48_2","unstructured":"Kreek M.J. 1979. Methadone in treatment: physiological and pharmacological issues.InHandbook on Drug Abuse. R.L. Dupont A. Goldstein & J. O'Connell Eds.: 57\u201386. National Institute of Drug Abuse\u2010ADAMHA\u2010DEW\u2010ODAP Executive Office of the President."},{"key":"e_1_2_4_49_2","unstructured":"Kreek M.J. 1999. Gender differences in the effects of opiates and cocaine: treatment implications.InGender and Its Effects on Psychopathology. E. Frank Ed.: 281\u2013299. Am. Psychiatric Press Inc. Washington DC."},{"key":"e_1_2_4_50_2","first-page":"377","article-title":"Antibodies to a retrovirus etiologically associated with Acquired Immunodeficiency Syndrome (AIDS) in populations with increased incidences of the syndrome","volume":"33","author":"Des Jarlais D.C.","year":"1984","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_4_51_2","unstructured":"Novick D.et al.1986. Antibody to LAV the putative agent of AIDS in parenteral drug abusers and methadone\u2010maintained patients: abstract of clinical research findings: therapeutic historical and ethical aspects.InProblems of Drug Dependence 1985. Proceedings of the 47th Annual Scientific Meeting of The Committee on Problems of Drug Dependence. L.S. Harris Ed. 67: 318\u2013320. IDA Research Monograph Series. Supt. of Docs. U.S. Gov. Print. Off. Washington DC. DHHS Pub. No. (ADM)86\u20101448."},{"key":"e_1_2_4_52_2","first-page":"15","article-title":"Acquired Immunodeficiency Syndrome and infection with hepatitis viruses in individuals abusing drugs by injection","volume":"38","author":"Novick D.M.","year":"1986","journal-title":"UN Bull. Narcotics"},{"key":"e_1_2_4_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890290307"},{"key":"e_1_2_4_54_2","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jama.1989.03420070058030","article-title":"HIV I Infection among intravenous drug users in Manhattan, New York City 1977 to 1987","volume":"261","author":"Des Jarlais D.C.","year":"1989","journal-title":"JAMA"},{"key":"e_1_2_4_55_2","unstructured":"Kreek M.J. 1990. HIV infection and parenteral drug abuse: ethical issues in diagnosis treatment research and the maintenance of confidentiality.InProceedings of the Third International Congress on Ethics in Medicine\u2010Nobel Conference Series. P. Allebeck & B. Jansson Eds.: 181\u2013187. Raven Press. New York."},{"key":"e_1_2_4_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.2.538"},{"key":"e_1_2_4_57_2","first-page":"111","article-title":"Hepatitis B serologic studies in narcotic users with chronic liver diseases","volume":"75","author":"Novick D.M.","year":"1981","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_4_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.172"},{"key":"e_1_2_4_59_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.26.1.8"},{"key":"e_1_2_4_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1985.tb05558.x"},{"key":"e_1_2_4_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1986.tb05131.x"},{"key":"e_1_2_4_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/158.4.795"},{"key":"e_1_2_4_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(90)90124-W"},{"key":"e_1_2_4_64_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.9444894.x"},{"key":"e_1_2_4_65_2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-3565(25)22252-2","article-title":"Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long\u2010term methadone maintenance patients","volume":"250","author":"Novick D.M.","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_4_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb03649.x"},{"key":"e_1_2_4_67_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v17n03_07"},{"key":"e_1_2_4_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.259.22.3299"},{"key":"e_1_2_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(91)90044-B"},{"key":"e_1_2_4_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02600025"},{"key":"e_1_2_4_71_2","unstructured":"Salsitz E.A.et al.1999. Methadone medical maintenance treating chronic opioid dependence in private medical practice: a summary review (1983\u20131989). J. Addictive Dis. In press."},{"key":"e_1_2_4_72_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.22.1936"},{"key":"e_1_2_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(96)00014-9"},{"key":"e_1_2_4_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(96)00672-3"},{"key":"e_1_2_4_75_2","first-page":"1","article-title":"Methadone disposition during the perinatal period in humans","volume":"11","author":"Kreek M.J.","year":"1979","journal-title":"Pharmac. Biochem. Behav."},{"key":"e_1_2_4_76_2","first-page":"75","article-title":"Thrombocytosis in the offspring of female mice receiving dl\u2010methadone","volume":"64","author":"Burstein Y.","year":"1980","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"e_1_2_4_77_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1630261"},{"key":"e_1_2_4_78_2","unstructured":"Kreek M.J. 1973. Physiologic implications of methadone treatment. Proceedings of the Fifth National Conference of Methadone Treatment NAPAN II\u2010NIMH pp. 824\u2013836."},{"key":"e_1_2_4_79_2","unstructured":"Cushman P. & M.J. Kreek. 1974. Some endocrinologic observations in narcotic Dependency: Medical Economic and Social Aspects. B. Stimmel Ed.:71\u201387. Stratton Intercontinental Medical Book Corp. New York."},{"key":"e_1_2_4_80_2","doi-asserted-by":"crossref","unstructured":"Stimmel B. & M.J. Kreek. 1975. Pharmacologic actions of heroin.InHeroin Dependency: Medical Economic and Social Aspects. B. Stimmel Ed.: 88\u201397. Stratton Intercontinental Medical Book Corp. New York.","DOI":"10.1001\/jama.1975.03260010090037"},{"key":"e_1_2_4_81_2","doi-asserted-by":"crossref","unstructured":"Stimmel B. & M.J. Kreek. 1975. Dependence tolerance and withdrawal.InHeroin Dependency: Medical Economic and Social Aspects. B. Stimmel Ed.: 88\u201397. Stratton Intercontinental Medical Book Corp. New York.","DOI":"10.1001\/jama.1975.03260010090037"},{"key":"e_1_2_4_82_2","doi-asserted-by":"crossref","unstructured":"Kreek M.J.et al.1981. Effects of chronic exogenous opioid administration on levels of one endogenous opioid (beta\u2010endorphin) in man.InAdvances in Endogenous and Exogenous Opioids. E. Simon & H.Takagi Eds.: 364\u2013366. Kodansha Ltd. Publishers. Tokyo.","DOI":"10.1016\/B978-0-444-80402-0.50123-6"},{"key":"e_1_2_4_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(83)90529-5"},{"key":"e_1_2_4_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/0143-4179(84)90081-7"},{"key":"e_1_2_4_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(87)90623-0"},{"key":"e_1_2_4_86_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1990.tb03438.x"},{"key":"e_1_2_4_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)91684-7"},{"key":"e_1_2_4_88_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1983.tb02910.x"},{"key":"e_1_2_4_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(86)90150-2"},{"key":"e_1_2_4_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(86)90437-6"},{"key":"e_1_2_4_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)82967-9"},{"key":"e_1_2_4_92_2","unstructured":"Kreek M.J. 1992. Effects of opiates opioid antagonists and cocaine on the endogenous opioid system: clinical and laboratory studies.InProblems of Drug Dependence 1991. Proceedings of the 53rd Annual Scientific Meeting The Committee on Problems of Drug Dependence Inc. National Institute on Drug Abuse Monograph. Harris L.S. Ed. 119: 44\u201348. Washington DC: Supt. of Docs. U.S. Gov. Print. Off. DHHS Pub. No. (ADM) 92\u20131888."},{"key":"e_1_2_4_93_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.106"},{"key":"e_1_2_4_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(93)80155-W"},{"key":"e_1_2_4_95_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952999509002710"},{"key":"e_1_2_4_96_2","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0022-3565(25)12388-4","article-title":"Effect of clonidine pretreatment on naloxone\u2010precipitated opiate withdrawal","volume":"276","author":"Rosen M.I.","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_4_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(97)90289-4"},{"key":"e_1_2_4_98_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1997.tb03856.x"},{"key":"e_1_2_4_99_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1998.tb03931.x"},{"key":"e_1_2_4_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00064-7"},{"key":"e_1_2_4_101_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197905033001817"},{"key":"e_1_2_4_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(80)90026-8"},{"key":"e_1_2_4_103_2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S0022-3565(25)24051-4","article-title":"Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes","volume":"271","author":"Emerson P.L.","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_4_104_2","unstructured":"Schluger J.et al.1998. Abnormal metyrapone tests during cocaine abstinence.InProblems of Drug Dependence 1997. Proceedings of the 59th Annual Scientific Meeting of the College on Problems of Drug Dependence. L. S. Harris Ed. 178: 105. National Institute of Drug Abuse Research Monograph Series Washington DC: Supt. of Docs. U.S. Gov. Print. Off. DHHS Pub. No. (ADM)98\u20104305."},{"key":"e_1_2_4_105_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.16.9608"},{"key":"e_1_2_4_106_2","unstructured":"Laforge K.S. & M.J. Kreek. 2000. Genetic contributions to protection from or vulnerability to addictive diseases.InProblems of Drug Dependence 1999. Proceedings of the 61st Annual Scientific Meeting of the College on Problems of Drug Dependence. L.S. Harris Ed. National Institute of Drug Abuse Research Monograph Series. In press."},{"key":"e_1_2_4_107_2","doi-asserted-by":"crossref","unstructured":"Laforge K.S.et al.2000. Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: potential in studies of addiction. Neuropsychiatric Genet. In press.","DOI":"10.1002\/1096-8628(20001009)96:5<604::AID-AJMG5>3.0.CO;2-F"},{"key":"e_1_2_4_108_2","doi-asserted-by":"publisher","DOI":"10.1080\/13556219772598"},{"key":"e_1_2_4_109_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000331"},{"key":"e_1_2_4_110_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.55.11.967"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2000.tb06683.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2000.tb06683.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T04:54:44Z","timestamp":1740286484000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2000.tb06683.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1111\/j.1749-6632.2000.tb06683.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06683.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}